• EMA accepted GSK’s filing to update Bexsero’s label to add a single booster dose for people aged 10+ previously vaccinated.
• The submission is backed by a Phase 3b study showing one booster dose boosted immune responses in 10-20 year olds vaccinated in infancy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GSK plc published the original content used to generate this news brief on July 20, 2026, and is solely responsible for the information contained therein.